Prostacyclin and risk of thromboembolism.
Varela-Aguilar
J M
JM
Sánchez-Hueso
M C
MC
González-Jimenez
M D
MD
García-Contreras
R F
RF
González dela Puente
M A
MA
D000818:Animals; D011464:Epoprostenol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced*
D010975:Platelet Aggregation Inhibitors; D011464:Epoprostenol